Entrada Therapeutics
IPOMaking Intracellular Therapeutics A Reality
Public · Boston, United States · Founded 2016 · $116.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- entradatx.com
- Total Funding
- $116.0M
- Last Round
- $116.0M Series BMar 2021
- Rounds
- 2
- Type
- Public
About
Biopharmaceutical company developing intracellular therapeutics for rare neuromuscular and other serious diseases.
Summary
Entrada Therapeutics is a Biotech company based in Boston, United States, founded in 2016. It has raised $116.0M in total across 2 rounds, most recently a $116.0M Series B round in Mar 2021. Investors include Roche.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...